Table X.
VA and VF recovery for the patients who received follow-ups.
| Short-term outcome, n (%) | Long-term outcome, n (%) | ||||||
|---|---|---|---|---|---|---|---|
|
|
|
||||||
| Variable | Patients, n | Improved | Unchanged | Worsened | Improved | Unchanged | Worsened |
| VA | |||||||
| Pre-op normal | 31 | 0 | 26 (83.9) | 5 (16.1) | 0 | 25 (80.6) | 6 (19.4) |
| Pre-op abnormal | 76 | 42 (55.3) | 25 (32.9) | 8 (10.5) | 46 (60.5) | 20 (26.3) | 10 (13.2) |
| Overall | 107 | 42 (39.3) | 51 (47.7) | 13 (12.1) | 46 (43.0) | 45 (42.1) | 16 (15.0) |
| VF | |||||||
| Pre-op normal | 49 | 0 | 30 (61.2) | 19 (38.8) | 0 | 28 (57.1) | 21 (42.9) |
| Pre-op abnormal | 58 | 17 (29.3) | 19 (32.8) | 22 (37.9) | 19 (32.8) | 14 (24.1) | 25 (43.1) |
| Overall | 107 | 17 (15.9) | 49 (45.8) | 41 (38.3) | 19 (17.8) | 42 (39.3) | 46 (43.0) |
VA, visual acuity; VF, visual field.